RUNX1 and acute lymphoblastic leukemia: Finally, at a functional level, we demonstrated that a CBFA2T3-mimicking peptide, whose expression was able to disrupt this activation loop by inhibiting RUNX1 activity, results in a decrease of BCP-ALL cell proliferation.